Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 107

1.

Understanding User Reactions and Interactions With an Internet-Based Intervention for Tinnitus Self-Management: Mixed-Methods Evaluation.

Greenwell K, Sereda M, Coulson NS, Hoare DJ.

Am J Audiol. 2019 Sep 13;28(3):697-713. doi: 10.1044/2019_AJA-18-0171. Epub 2019 Sep 4.

PMID:
31487477
2.

Cochrane corner: Sound therapy (using amplification devices and/or sound generators) for tinnitus.

Brennan-Jones CG, Thomas A, Hoare DJ, Sereda M.

Int J Audiol. 2019 Jul 30:1-5. doi: 10.1080/14992027.2019.1643503. [Epub ahead of print]

PMID:
31361173
3.

Myelinating Glia-Specific Deletion of Fbxo7 in Mice Triggers Axonal Degeneration in the Central Nervous System Together with Peripheral Neuropathy.

Joseph S, Vingill S, Jahn O, Fledrich R, Werner HB, Katona I, Möbius W, Mitkovski M, Huang Y, Weis J, Sereda MW, Schulz JB, Nave KA, Stegmüller J.

J Neurosci. 2019 Jul 10;39(28):5606-5626. doi: 10.1523/JNEUROSCI.3094-18.2019. Epub 2019 May 13.

PMID:
31085610
4.

Publisher Correction: NRG1 type I dependent autoparacrine stimulation of Schwann cells in onion bulbs of peripheral neuropathies.

Fledrich R, Akkermann D, Schütza V, Abdelaal TA, Hermes D, Schäffner E, Soto-Bernardini MC, Götze T, Klink A, Kusch K, Krueger M, Kungl T, Frydrychowicz C, Möbius W, Brück W, Mueller WC, Bechmann I, Sereda MW, Schwab MH, Nave KA, Stassart RM.

Nat Commun. 2019 Apr 16;10(1):1840. doi: 10.1038/s41467-019-09886-4.

5.

NRG1 type I dependent autoparacrine stimulation of Schwann cells in onion bulbs of peripheral neuropathies.

Fledrich R, Akkermann D, Schütza V, Abdelaal TA, Hermes D, Schäffner E, Soto-Bernardini MC, Götze T, Klink A, Kusch K, Krueger M, Kungl T, Frydrychowicz C, Möbius W, Brück W, Mueller WC, Bechmann I, Sereda MW, Schwab MH, Nave KA, Stassart RM.

Nat Commun. 2019 Apr 1;10(1):1467. doi: 10.1038/s41467-019-09385-6. Erratum in: Nat Commun. 2019 Apr 16;10(1):1840.

6.

Standardised profiling for tinnitus research: The European School for Interdisciplinary Tinnitus Research Screening Questionnaire (ESIT-SQ).

Genitsaridi E, Partyka M, Gallus S, Lopez-Escamez JA, Schecklmann M, Mielczarek M, Trpchevska N, Santacruz JL, Schoisswohl S, Riha C, Lourenco M, Biswas R, Liyanage N, Cederroth CR, Perez-Carpena P, Devos J, Fuller T, Edvall NK, Hellberg MP, D'Antonio A, Gerevini S, Sereda M, Rein A, Kypraios T, Hoare DJ, Londero A, Pryss R, Schlee W, Hall DA.

Hear Res. 2019 Jun;377:353-359. doi: 10.1016/j.heares.2019.02.017. Epub 2019 Mar 2.

7.

Gap-induced inhibition of the post-auricular muscle response in humans and guinea pigs.

Wilson CA, Berger JI, de Boer J, Sereda M, Palmer AR, Hall DA, Wallace MN.

Hear Res. 2019 Mar 15;374:13-23. doi: 10.1016/j.heares.2019.01.009. Epub 2019 Jan 17.

8.

Mobile Apps for Management of Tinnitus: Users' Survey, Quality Assessment, and Content Analysis.

Sereda M, Smith S, Newton K, Stockdale D.

JMIR Mhealth Uhealth. 2019 Jan 23;7(1):e10353. doi: 10.2196/10353.

9.

Early short-term PXT3003 combinational therapy delays disease onset in a transgenic rat model of Charcot-Marie-Tooth disease 1A (CMT1A).

Prukop T, Stenzel J, Wernick S, Kungl T, Mroczek M, Adam J, Ewers D, Nabirotchkin S, Nave KA, Hajj R, Cohen D, Sereda MW.

PLoS One. 2019 Jan 16;14(1):e0209752. doi: 10.1371/journal.pone.0209752. eCollection 2019.

10.

Sound therapy (using amplification devices and/or sound generators) for tinnitus.

Sereda M, Xia J, El Refaie A, Hall DA, Hoare DJ.

Cochrane Database Syst Rev. 2018 Dec 27;12:CD013094. doi: 10.1002/14651858.CD013094.pub2.

PMID:
30589445
11.

Targeting myelin lipid metabolism as a potential therapeutic strategy in a model of CMT1A neuropathy.

Fledrich R, Abdelaal T, Rasch L, Bansal V, Schütza V, Brügger B, Lüchtenborg C, Prukop T, Stenzel J, Rahman RU, Hermes D, Ewers D, Möbius W, Ruhwedel T, Katona I, Weis J, Klein D, Martini R, Brück W, Müller WC, Bonn S, Bechmann I, Nave KA, Stassart RM, Sereda MW.

Nat Commun. 2018 Aug 2;9(1):3025. doi: 10.1038/s41467-018-05420-0.

12.

Clinical Interventions for Hyperacusis in Adults: A Scoping Review to Assess the Current Position and Determine Priorities for Research.

Fackrell K, Potgieter I, Shekhawat GS, Baguley DM, Sereda M, Hoare DJ.

Biomed Res Int. 2017;2017:2723715. doi: 10.1155/2017/2723715. Epub 2017 Oct 9. Review.

13.

Combined Amplification and Sound Generation for Tinnitus: A Scoping Review.

Tutaj L, Hoare DJ, Sereda M.

Ear Hear. 2018 May/Jun;39(3):412-422. doi: 10.1097/AUD.0000000000000516. Review.

14.

Biomarkers predict outcome in Charcot-Marie-Tooth disease 1A.

Fledrich R, Mannil M, Leha A, Ehbrecht C, Solari A, Pelayo-Negro AL, Berciano J, Schlotter-Weigel B, Schnizer TJ, Prukop T, Garcia-Angarita N, Czesnik D, Haberlová J, Mazanec R, Paulus W, Beissbarth T, Walter MC, Triaal C, Hogrel JY, Dubourg O, Schenone A, Baets J, De Jonghe P, Shy ME, Horvath R, Pareyson D, Seeman P, Young P, Sereda MW.

J Neurol Neurosurg Psychiatry. 2017 Nov;88(11):941-952. doi: 10.1136/jnnp-2017-315721. Epub 2017 Aug 31.

PMID:
28860329
15.

Peroxisomal dysfunctions cause lysosomal storage and axonal Kv1 channel redistribution in peripheral neuropathy.

Kleinecke S, Richert S, de Hoz L, Brügger B, Kungl T, Asadollahi E, Quintes S, Blanz J, McGonigal R, Naseri K, Sereda MW, Sachsenheimer T, Lüchtenborg C, Möbius W, Willison H, Baes M, Nave KA, Kassmann CM.

Elife. 2017 May 4;6. pii: e23332. doi: 10.7554/eLife.23332.

16.

Rho Kinase Inhibition with Fasudil in the SOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis-Symptomatic Treatment Potential after Disease Onset.

Günther R, Balck A, Koch JC, Nientiedt T, Sereda M, Bähr M, Lingor P, Tönges L.

Front Pharmacol. 2017 Jan 31;8:17. doi: 10.3389/fphar.2017.00017. eCollection 2017.

17.

Pre-market version of a commercially available hearing instrument with a tinnitus sound generator: feasibility of evaluation in a clinical trial.

Sereda M, Davies J, Hall DA.

Int J Audiol. 2017 Apr;56(4):286-294. doi: 10.1080/14992027.2016.1254822. Epub 2016 Nov 25.

PMID:
27885869
18.

Tolerability and efficacy study of P2X7 inhibition in experimental Charcot-Marie-Tooth type 1A (CMT1A) neuropathy.

Sociali G, Visigalli D, Prukop T, Cervellini I, Mannino E, Venturi C, Bruzzone S, Sereda MW, Schenone A.

Neurobiol Dis. 2016 Nov;95:145-57. doi: 10.1016/j.nbd.2016.07.017. Epub 2016 Jul 16.

PMID:
27431093
19.

Electrical Stimulation of the Ear, Head, Cranial Nerve, or Cortex for the Treatment of Tinnitus: A Scoping Review.

Hoare DJ, Adjamian P, Sereda M.

Neural Plast. 2016;2016:5130503. doi: 10.1155/2016/5130503. Epub 2016 Jun 15. Review.

20.

Zeb2 is essential for Schwann cell differentiation, myelination and nerve repair.

Quintes S, Brinkmann BG, Ebert M, Fröb F, Kungl T, Arlt FA, Tarabykin V, Huylebroeck D, Meijer D, Suter U, Wegner M, Sereda MW, Nave KA.

Nat Neurosci. 2016 Aug;19(8):1050-1059. doi: 10.1038/nn.4321. Epub 2016 Jun 13.

21.

A systematic review of techniques and effects of self-help interventions for tinnitus: Application of taxonomies from health psychology.

Greenwell K, Sereda M, Coulson N, El Refaie A, Hoare DJ.

Int J Audiol. 2016 Jul;55 Suppl 3:S79-89. doi: 10.3109/14992027.2015.1137363. Epub 2016 May 5. Review.

PMID:
27146036
22.

Understanding User Reactions and Interactions With an Internet-Based Intervention for Tinnitus Self-Management: Mixed-Methods Process Evaluation Protocol.

Greenwell K, Sereda M, Coulson N, Hoare DJ.

JMIR Res Protoc. 2016 Mar 23;5(1):e49. doi: 10.2196/resprot.5008.

23.

Hyperacusis Questionnaire as a Tool for Measuring Hypersensitivity to Sound in a Tinnitus Research Population.

Fackrell K, Fearnley C, Hoare DJ, Sereda M.

Biomed Res Int. 2015;2015:290425. doi: 10.1155/2015/290425. Epub 2015 Oct 18.

24.

Proteolipid protein modulates preservation of peripheral axons and premature death when myelin protein zero is lacking.

Patzig J, Kusch K, Fledrich R, Eichel MA, Lüders KA, Möbius W, Sereda MW, Nave KA, Martini R, Werner HB.

Glia. 2016 Jan;64(1):155-74. doi: 10.1002/glia.22922. Epub 2015 Sep 22.

PMID:
26393339
25.

The role of combined SNV and CNV burden in patients with distal symmetric polyneuropathy.

Pehlivan D, Beck CR, Okamoto Y, Harel T, Akdemir ZH, Jhangiani SN, Withers MA, Goksungur MT, Carvalho CM, Czesnik D, Gonzaga-Jauregui C, Wiszniewski W, Muzny DM, Gibbs RA, Rautenstrauss B, Sereda MW, Lupski JR.

Genet Med. 2016 May;18(5):443-51. doi: 10.1038/gim.2015.124. Epub 2015 Sep 17.

26.

Curcumin therapy in a Plp1 transgenic mouse model of Pelizaeus-Merzbacher disease.

Epplen DB, Prukop T, Nientiedt T, Albrecht P, Arlt FA, Stassart RM, Kassmann CM, Methner A, Nave KA, Werner HB, Sereda MW.

Ann Clin Transl Neurol. 2015 Aug;2(8):787-96. doi: 10.1002/acn3.219. Epub 2015 Jun 24.

27.

A brief review of recent Charcot-Marie-Tooth research and priorities.

Ekins S, Litterman NK, Arnold RJ, Burgess RW, Freundlich JS, Gray SJ, Higgins JJ, Langley B, Willis DE, Notterpek L, Pleasure D, Sereda MW, Moore A.

F1000Res. 2015 Feb 26;4:53. doi: 10.12688/f1000research.6160.1. eCollection 2015. Review.

28.

Source space estimation of oscillatory power and brain connectivity in tinnitus.

Zobay O, Palmer AR, Hall DA, Sereda M, Adjamian P.

PLoS One. 2015 Mar 23;10(3):e0120123. doi: 10.1371/journal.pone.0120123. eCollection 2015.

29.

Consensus on Hearing Aid Candidature and Fitting for Mild Hearing Loss, With and Without Tinnitus: Delphi Review.

Sereda M, Hoare DJ, Nicholson R, Smith S, Hall DA.

Ear Hear. 2015 Jul-Aug;36(4):417-29. doi: 10.1097/AUD.0000000000000140.

30.

Polytherapy with a combination of three repurposed drugs (PXT3003) down-regulates Pmp22 over-expression and improves myelination, axonal and functional parameters in models of CMT1A neuropathy.

Chumakov I, Milet A, Cholet N, Primas G, Boucard A, Pereira Y, Graudens E, Mandel J, Laffaire J, Foucquier J, Glibert F, Bertrand V, Nave KA, Sereda MW, Vial E, Guedj M, Hajj R, Nabirotchkin S, Cohen D.

Orphanet J Rare Dis. 2014 Dec 10;9:201. doi: 10.1186/s13023-014-0201-x.

31.

Relationship between tinnitus pitch and edge of hearing loss in individuals with a narrow tinnitus bandwidth.

Sereda M, Edmondson-Jones M, Hall DA.

Int J Audiol. 2015 Apr;54(4):249-56. doi: 10.3109/14992027.2014.979373. Epub 2014 Dec 3.

32.

Annexin A2 regulates TRPA1-dependent nociception.

Avenali L, Narayanan P, Rouwette T, Cervellini I, Sereda M, Gomez-Varela D, Schmidt M.

J Neurosci. 2014 Oct 29;34(44):14506-16. doi: 10.1523/JNEUROSCI.1801-14.2014.

33.

Gameplay as a source of intrinsic motivation in a randomized controlled trial of auditory training for tinnitus.

Hoare DJ, Van Labeke N, McCormack A, Sereda M, Smith S, Al Taher H, Kowalkowski VL, Sharples M, Hall DA.

PLoS One. 2014 Sep 12;9(9):e107430. doi: 10.1371/journal.pone.0107430. eCollection 2014.

34.

Nucleoside triphosphate diphosphohydrolase-1 ectonucleotidase is required for normal vas deferens contraction and male fertility through maintaining P2X1 receptor function.

Kauffenstein G, Pelletier J, Lavoie EG, Kukulski F, Martín-Satué M, Dufresne SS, Frenette J, Ribas Fürstenau C, Sereda MJ, Toutain B, Henrion D, Sullivan R, Vial C, Sévigny J.

J Biol Chem. 2014 Oct 10;289(41):28629-39. doi: 10.1074/jbc.M114.604082. Epub 2014 Aug 25.

35.

Soluble neuregulin-1 modulates disease pathogenesis in rodent models of Charcot-Marie-Tooth disease 1A.

Fledrich R, Stassart RM, Klink A, Rasch LM, Prukop T, Haag L, Czesnik D, Kungl T, Abdelaal TA, Keric N, Stadelmann C, Brück W, Nave KA, Sereda MW.

Nat Med. 2014 Sep;20(9):1055-61. doi: 10.1038/nm.3664. Epub 2014 Aug 24.

PMID:
25150498
36.

Selected items from the Charcot-Marie-Tooth (CMT) Neuropathy Score and secondary clinical outcome measures serve as sensitive clinical markers of disease severity in CMT1A patients.

Mannil M, Solari A, Leha A, Pelayo-Negro AL, Berciano J, Schlotter-Weigel B, Walter MC, Rautenstrauss B, Schnizer TJ, Schenone A, Seeman P, Kadian C, Schreiber O, Angarita NG, Fabrizi GM, Gemignani F, Padua L, Santoro L, Quattrone A, Vita G, Calabrese D; CMT-TRIAAL/CMT-TRAUK Group, Young P, Laurà M, Haberlová J, Mazanec R, Paulus W, Beissbarth T, Shy ME, Reilly MM, Pareyson D, Sereda MW.

Neuromuscul Disord. 2014 Nov;24(11):1003-17. doi: 10.1016/j.nmd.2014.06.431. Epub 2014 Jun 19.

PMID:
25085517
37.

Progesterone antagonist therapy in a Pelizaeus-Merzbacher mouse model.

Prukop T, Epplen DB, Nientiedt T, Wichert SP, Fledrich R, Stassart RM, Rossner MJ, Edgar JM, Werner HB, Nave KA, Sereda MW.

Am J Hum Genet. 2014 Apr 3;94(4):533-46. doi: 10.1016/j.ajhg.2014.03.001. Epub 2014 Mar 27.

38.

Amplification with hearing aids for patients with tinnitus and co-existing hearing loss.

Hoare DJ, Edmondson-Jones M, Sereda M, Akeroyd MA, Hall D.

Cochrane Database Syst Rev. 2014 Jan 31;(1):CD010151. doi: 10.1002/14651858.CD010151.pub2. Review.

PMID:
24482186
39.

Rho kinase inhibition modulates microglia activation and improves survival in a model of amyotrophic lateral sclerosis.

Tönges L, Günther R, Suhr M, Jansen J, Balck A, Saal KA, Barski E, Nientied T, Götz AA, Koch JC, Mueller BK, Weishaupt JH, Sereda MW, Hanisch UK, Bähr M, Lingor P.

Glia. 2014 Feb;62(2):217-32. doi: 10.1002/glia.22601. Epub 2013 Dec 6.

PMID:
24311453
40.

Auditory evoked magnetic fields in individuals with tinnitus.

Sereda M, Adjamian P, Edmondson-Jones M, Palmer AR, Hall DA.

Hear Res. 2013 Aug;302:50-9. doi: 10.1016/j.heares.2013.04.006. Epub 2013 Apr 29.

41.

Recent technological advances in sound-based approaches to tinnitus treatment: a review of efficacy considered against putative physiological mechanisms.

Hoare DJ, Adjamian P, Sereda M, Hall DA.

Noise Health. 2013 Mar-Apr;15(63):107-16. doi: 10.4103/1463-1741.110292. Review.

42.

A role for Schwann cell-derived neuregulin-1 in remyelination.

Stassart RM, Fledrich R, Velanac V, Brinkmann BG, Schwab MH, Meijer D, Sereda MW, Nave KA.

Nat Neurosci. 2013 Jan;16(1):48-54. doi: 10.1038/nn.3281. Epub 2012 Dec 9.

PMID:
23222914
43.

Neuromagnetic indicators of tinnitus and tinnitus masking in patients with and without hearing loss.

Adjamian P, Sereda M, Zobay O, Hall DA, Palmer AR.

J Assoc Res Otolaryngol. 2012 Oct;13(5):715-31. doi: 10.1007/s10162-012-0340-5. Epub 2012 Jul 12.

44.

Glycolytic oligodendrocytes maintain myelin and long-term axonal integrity.

Fünfschilling U, Supplie LM, Mahad D, Boretius S, Saab AS, Edgar J, Brinkmann BG, Kassmann CM, Tzvetanova ID, Möbius W, Diaz F, Meijer D, Suter U, Hamprecht B, Sereda MW, Moraes CT, Frahm J, Goebbels S, Nave KA.

Nature. 2012 Apr 29;485(7399):517-21. doi: 10.1038/nature11007.

45.

Murine therapeutic models for Charcot-Marie-Tooth (CMT) disease.

Fledrich R, Stassart RM, Sereda MW.

Br Med Bull. 2012 Jun;102:89-113. doi: 10.1093/bmb/lds010. Epub 2012 May 2. Review.

PMID:
22551516
46.

Genetic disruption of Pten in a novel mouse model of tomaculous neuropathy.

Goebbels S, Oltrogge JH, Wolfer S, Wieser GL, Nientiedt T, Pieper A, Ruhwedel T, Groszer M, Sereda MW, Nave KA.

EMBO Mol Med. 2012 Jun;4(6):486-99. doi: 10.1002/emmm.201200227. Epub 2012 Apr 4.

47.

Lithium enhances remyelination of peripheral nerves.

Makoukji J, Belle M, Meffre D, Stassart R, Grenier J, Shackleford G, Fledrich R, Fonte C, Branchu J, Goulard M, de Waele C, Charbonnier F, Sereda MW, Baulieu EE, Schumacher M, Bernard S, Massaad C.

Proc Natl Acad Sci U S A. 2012 Mar 6;109(10):3973-8. doi: 10.1073/pnas.1121367109. Epub 2012 Feb 21.

48.

A rat model of Charcot-Marie-Tooth disease 1A recapitulates disease variability and supplies biomarkers of axonal loss in patients.

Fledrich R, Schlotter-Weigel B, Schnizer TJ, Wichert SP, Stassart RM, Meyer zu Hörste G, Klink A, Weiss BG, Haag U, Walter MC, Rautenstrauss B, Paulus W, Rossner MJ, Sereda MW.

Brain. 2012 Jan;135(Pt 1):72-87. doi: 10.1093/brain/awr322. Epub 2011 Dec 20.

PMID:
22189569
49.

Sodium-dependent vitamin C transporter 2 deficiency causes hypomyelination and extracellular matrix defects in the peripheral nervous system.

Gess B, Röhr D, Fledrich R, Sereda MW, Kleffner I, Humberg A, Nowitzki J, Strecker JK, Halfter H, Young P.

J Neurosci. 2011 Nov 23;31(47):17180-92. doi: 10.1523/JNEUROSCI.3457-11.2011.

50.

A role for myelin-associated peroxisomes in maintaining paranodal loops and axonal integrity.

Kassmann CM, Quintes S, Rietdorf J, Möbius W, Sereda MW, Nientiedt T, Saher G, Baes M, Nave KA.

FEBS Lett. 2011 Jul 21;585(14):2205-11. doi: 10.1016/j.febslet.2011.05.032. Epub 2011 May 23.

Supplemental Content

Loading ...
Support Center